The emerging role of obesity, diet and lipid metabolism in prostate cancer

Matteo Ferro, Daniela Terracciano, Carlo Buonerba, Giuseppe Lucarelli, Danilo Bottero, Sisto Perdonà, Riccardo Autorino, Alessandro Serino, Francesco Cantiello, Rocco Damiano, Iulia Andras, Sabino De Placido, Giuseppe Di Lorenzo, Michele Battaglia, Barbara A Jereczek-Fossa, Vincenzo Mirone, Ottavio De Cobelli

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Obesity is associated with an increased risk of a number of serious medical conditions, including cancer. As far as prostate cancer is concerned, obesity is associated with an increased risk of high-grade tumors, which is possibly related to lower androgen levels. Diet may also affect prostate cancer risk since countries with a higher dietary fat intake also present higher prostate cancer mortality rates. Interestingly, prostate cancer is associated with a number of metabolic alterations that may provide valuable diagnostic and therapeutic targets. This review explores the available clinical as well as biological evidence supporting the relationship between obesity, diet, alteration in metabolic pathways and prostate cancer.

Original languageEnglish
Pages (from-to)285-293
Number of pages9
JournalFuture Oncology
Volume13
Issue number3
DOIs
Publication statusPublished - Feb 2017

Fingerprint

Lipid Metabolism
Prostatic Neoplasms
Obesity
Diet
Dietary Fats
Metabolic Networks and Pathways
Androgens
Neoplasms
Mortality
Therapeutics

Keywords

  • Adipocytes/metabolism
  • Cell Transformation, Neoplastic/metabolism
  • Diet
  • Humans
  • Lipid Metabolism
  • Male
  • Obesity/complications
  • Prostatic Neoplasms/etiology

Cite this

The emerging role of obesity, diet and lipid metabolism in prostate cancer. / Ferro, Matteo; Terracciano, Daniela; Buonerba, Carlo; Lucarelli, Giuseppe; Bottero, Danilo; Perdonà, Sisto; Autorino, Riccardo; Serino, Alessandro; Cantiello, Francesco; Damiano, Rocco; Andras, Iulia; De Placido, Sabino; Di Lorenzo, Giuseppe; Battaglia, Michele; Jereczek-Fossa, Barbara A; Mirone, Vincenzo; De Cobelli, Ottavio.

In: Future Oncology, Vol. 13, No. 3, 02.2017, p. 285-293.

Research output: Contribution to journalReview article

Ferro, M, Terracciano, D, Buonerba, C, Lucarelli, G, Bottero, D, Perdonà, S, Autorino, R, Serino, A, Cantiello, F, Damiano, R, Andras, I, De Placido, S, Di Lorenzo, G, Battaglia, M, Jereczek-Fossa, BA, Mirone, V & De Cobelli, O 2017, 'The emerging role of obesity, diet and lipid metabolism in prostate cancer', Future Oncology, vol. 13, no. 3, pp. 285-293. https://doi.org/10.2217/fon-2016-0217
Ferro, Matteo ; Terracciano, Daniela ; Buonerba, Carlo ; Lucarelli, Giuseppe ; Bottero, Danilo ; Perdonà, Sisto ; Autorino, Riccardo ; Serino, Alessandro ; Cantiello, Francesco ; Damiano, Rocco ; Andras, Iulia ; De Placido, Sabino ; Di Lorenzo, Giuseppe ; Battaglia, Michele ; Jereczek-Fossa, Barbara A ; Mirone, Vincenzo ; De Cobelli, Ottavio. / The emerging role of obesity, diet and lipid metabolism in prostate cancer. In: Future Oncology. 2017 ; Vol. 13, No. 3. pp. 285-293.
@article{178b7911986348838ea785609f66e8b8,
title = "The emerging role of obesity, diet and lipid metabolism in prostate cancer",
abstract = "Obesity is associated with an increased risk of a number of serious medical conditions, including cancer. As far as prostate cancer is concerned, obesity is associated with an increased risk of high-grade tumors, which is possibly related to lower androgen levels. Diet may also affect prostate cancer risk since countries with a higher dietary fat intake also present higher prostate cancer mortality rates. Interestingly, prostate cancer is associated with a number of metabolic alterations that may provide valuable diagnostic and therapeutic targets. This review explores the available clinical as well as biological evidence supporting the relationship between obesity, diet, alteration in metabolic pathways and prostate cancer.",
keywords = "Adipocytes/metabolism, Cell Transformation, Neoplastic/metabolism, Diet, Humans, Lipid Metabolism, Male, Obesity/complications, Prostatic Neoplasms/etiology",
author = "Matteo Ferro and Daniela Terracciano and Carlo Buonerba and Giuseppe Lucarelli and Danilo Bottero and Sisto Perdon{\`a} and Riccardo Autorino and Alessandro Serino and Francesco Cantiello and Rocco Damiano and Iulia Andras and {De Placido}, Sabino and {Di Lorenzo}, Giuseppe and Michele Battaglia and Jereczek-Fossa, {Barbara A} and Vincenzo Mirone and {De Cobelli}, Ottavio",
year = "2017",
month = "2",
doi = "10.2217/fon-2016-0217",
language = "English",
volume = "13",
pages = "285--293",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - The emerging role of obesity, diet and lipid metabolism in prostate cancer

AU - Ferro, Matteo

AU - Terracciano, Daniela

AU - Buonerba, Carlo

AU - Lucarelli, Giuseppe

AU - Bottero, Danilo

AU - Perdonà, Sisto

AU - Autorino, Riccardo

AU - Serino, Alessandro

AU - Cantiello, Francesco

AU - Damiano, Rocco

AU - Andras, Iulia

AU - De Placido, Sabino

AU - Di Lorenzo, Giuseppe

AU - Battaglia, Michele

AU - Jereczek-Fossa, Barbara A

AU - Mirone, Vincenzo

AU - De Cobelli, Ottavio

PY - 2017/2

Y1 - 2017/2

N2 - Obesity is associated with an increased risk of a number of serious medical conditions, including cancer. As far as prostate cancer is concerned, obesity is associated with an increased risk of high-grade tumors, which is possibly related to lower androgen levels. Diet may also affect prostate cancer risk since countries with a higher dietary fat intake also present higher prostate cancer mortality rates. Interestingly, prostate cancer is associated with a number of metabolic alterations that may provide valuable diagnostic and therapeutic targets. This review explores the available clinical as well as biological evidence supporting the relationship between obesity, diet, alteration in metabolic pathways and prostate cancer.

AB - Obesity is associated with an increased risk of a number of serious medical conditions, including cancer. As far as prostate cancer is concerned, obesity is associated with an increased risk of high-grade tumors, which is possibly related to lower androgen levels. Diet may also affect prostate cancer risk since countries with a higher dietary fat intake also present higher prostate cancer mortality rates. Interestingly, prostate cancer is associated with a number of metabolic alterations that may provide valuable diagnostic and therapeutic targets. This review explores the available clinical as well as biological evidence supporting the relationship between obesity, diet, alteration in metabolic pathways and prostate cancer.

KW - Adipocytes/metabolism

KW - Cell Transformation, Neoplastic/metabolism

KW - Diet

KW - Humans

KW - Lipid Metabolism

KW - Male

KW - Obesity/complications

KW - Prostatic Neoplasms/etiology

U2 - 10.2217/fon-2016-0217

DO - 10.2217/fon-2016-0217

M3 - Review article

VL - 13

SP - 285

EP - 293

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 3

ER -